105 related articles for article (PubMed ID: 32797765)
1. Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells.
Yang XG; Li YF; Wang YJ; Kong RH; Wang D
Pharmazie; 2020 Sep; 75(9):412-416. PubMed ID: 32797765
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Yang XG; Mou YH; Wang YJ; Wang J; Li YY; Kong RH; Ding M; Wang D; Guo C
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974737
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
4. Repurposing antitubercular agent isoniazid for treatment of prostate cancer.
Lv Q; Wang D; Yang Z; Yang J; Zhang R; Yang X; Wang M; Wang Y
Biomater Sci; 2018 Dec; 7(1):296-306. PubMed ID: 30468220
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.
Yang XG; Li YY; Zhao DX; Cui W; Li H; Li XY; Li YX; Wang D
Oncol Rep; 2021 Mar; 45(3):1306-1314. PubMed ID: 33650669
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis.
Kim WY; Won M; Salimi A; Sharma A; Lim JH; Kwon SH; Jeon JY; Lee JY; Kim JS
Chem Commun (Camb); 2019 Oct; 55(88):13267-13270. PubMed ID: 31621760
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Xu S; Adisetiyo H; Tamura S; Grande F; Garofalo A; Roy-Burman P; Neamati N
Br J Cancer; 2015 Jul; 113(2):242-51. PubMed ID: 26103574
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.
Wu JB; Shi C; Chu GC; Xu Q; Zhang Y; Li Q; Yu JS; Zhau HE; Chung LW
Biomaterials; 2015 Oct; 67():1-10. PubMed ID: 26197410
[TBL] [Abstract][Full Text] [Related]
10. MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.
Lin YC; Chang YT; Campbell M; Lin TP; Pan CC; Lee HC; Shih JC; Chang PC
Sci Rep; 2017 Apr; 7():46338. PubMed ID: 28402333
[TBL] [Abstract][Full Text] [Related]
11. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
Li J; Pu T; Yin L; Li Q; Liao CP; Wu BJ
Oncogene; 2020 Apr; 39(16):3305-3321. PubMed ID: 32066880
[TBL] [Abstract][Full Text] [Related]
12. Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
Gaur S; Gross ME; Liao CP; Qian B; Shih JC
Prostate; 2019 May; 79(6):667-677. PubMed ID: 30693539
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.
Han H; Li H; Ma Y; Zhao Z; An Q; Zhao J; Shi C
Cancer Lett; 2023 Jun; 563():216188. PubMed ID: 37076041
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy.
Jin C; Li J; Yang X; Zhou S; Li C; Yu J; Wang Z; Wang D; He Z; Jiang Y; Wang Y
Int J Pharm; 2023 Jan; 631():122509. PubMed ID: 36549403
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
16. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
17. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
18. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells.
Zarmouh NO; Messeha SS; Mateeva N; Gangapuram M; Flowers K; Eyunni SVK; Zhang W; Redda KK; Soliman KFA
Molecules; 2020 May; 25(9):. PubMed ID: 32403270
[TBL] [Abstract][Full Text] [Related]
19. Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.
Qin J; Zhang C; Zhao Y; Tan D; Wu P; Shui X; Qin W; Ge X; Shi C
Mol Pharm; 2023 Dec; 20(12):6226-6236. PubMed ID: 37955533
[TBL] [Abstract][Full Text] [Related]
20. Heptamethine Cyanine Dye Mediated Drug Delivery: Hype or Hope.
Choi PJ; Park TIH; Cooper E; Dragunow M; Denny WA; Jose J
Bioconjug Chem; 2020 Jul; 31(7):1724-1739. PubMed ID: 32530288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
